Condition

Primary Plasma Cell Leukemia clinical trials and research

As of November 12, 2026, Find a Trial lists 3 Primary Plasma Cell Leukemia clinical trials that are recruiting, at sites in 2 countries (most in China (2), Greece (1)). 1 was first registered in the last 30 days. By phase: Phase 2 (3). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.

Newest Primary Plasma Cell Leukemia clinical trials

StudyPhaseWhereStatusRegistered
QLS4131 plus isatuximab for newly diagnosed primary plasma cell leukemia Phase 2 Tianjin, Tianjin Municipality Recruiting Oct 29, 2026
Evaluating a new treatment approach for primary plasma cell leukemia Phase 2 Athens, Attica and 6 other locations Recruiting Oct 10, 2024
Evaluating a new treatment for ultra high-risk multiple myeloma patients Phase 2 Wuhan, Hubei Recruiting Nov 21, 2023

All recruiting trials (3)

Related topics

DaratumumabMultiple MyelomaIsatuximab

Quick answers

How many Primary Plasma Cell Leukemia clinical trials are recruiting right now?

3, as of November 12, 2026. 1 of them was first registered in the last 30 days. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 2 countries. The most sites are in China (2 trials), Greece (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 3. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →

Last reviewed 2026-11-12 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.